Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-01

Clinical Trial Update: HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol [NA]

View source ↗

Summary

This entry notes completion of a clinical trial protocol evaluating cidofovir (HPMPC) for peripheral cytomegalovirus retinitis in HIV-infected patients, as reco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cidofovir (cidofovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Retinitis, HIV Infections | NA | Status: COMPLETED